Chile’s National Economic Prosecutor (FNE) has said it received a new complaint regarding possible instances of collusion between major drug-store chains, this time affecting the Valdivia region. The complaint, presented by the Movimiento Autónomo Regional de Los Rios (Los Rios Autonomous Regional Movement), has sought to bring attention to this problem, which they claim affects several communal areas.
Miguel Ángel Carrasco, a physician and member of the Los Ríos movement, explained that their suspicions were raised due to the minimal difference in prices found among the most common medications used by Chilean consumers. The group has gathered and presented the FNE with data collected from communal villages in the Valdivia and Union regions, with price comparisons for various brands of medication, including anti-inflammatory and anti-anxiety medication.
Full Content: Bio Bio Chile
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Big Tech Braces for Potential Changes Under a Second Trump Presidency
Nov 6, 2024 by
CPI
Trump’s Potential Shift in US Antitrust Policy Raises Questions for Big Tech and Mergers
Nov 6, 2024 by
CPI
EU Set to Fine Apple in First Major Enforcement of Digital Markets Act
Nov 5, 2024 by
CPI
Six Indicted in Federal Bid-Rigging Schemes Involving Government IT Contracts
Nov 5, 2024 by
CPI
Ireland Secures First €3 Billion Apple Tax Payment, Boosting Exchequer Funds
Nov 5, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Remedies Revisited
Oct 30, 2024 by
CPI
Fixing the Fix: Updating Policy on Merger Remedies
Oct 30, 2024 by
CPI
Methodology Matters: The 2017 FTC Remedies Study
Oct 30, 2024 by
CPI
U.S. v. AT&T: Five Lessons for Vertical Merger Enforcement
Oct 30, 2024 by
CPI
The Search for Antitrust Remedies in Tech Leads Beyond Antitrust
Oct 30, 2024 by
CPI